Fujiya Co., Ltd. logo

Fujiya Co., Ltd. (2211)

Market Closed
13 Aug, 06:00
JPX JPX
¥
2,447. 00
+19
+0.7825%
¥
- Market Cap
- P/E Ratio
0.6% Div Yield
34,200 Volume
- Eps
¥ 2,428
Previous Close
Add Transaction
Day Range
2,422 2,455
Year Range
2,265 2,685
Want to track 2211 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

2211 closed yesterday higher at ¥2,447, an increase of 0.7825% from Wednesday's close, completing a monthly increase of 4.1277% or ¥97. Over the past 12 months, 2211 stock lost -3.0507%.
2211 pays dividends to its shareholders, with the most recent payment made on Mar 01, 2026. The next estimated payment will be in In 6 months on Mar 01, 2027 for a total of ¥30.
The last earnings report, released on Apr 27, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Fujiya Co., Ltd. has completed 1 stock splits, with the recent split occurring on Jun 28, 2017.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on HKEX (HKD).

2211 Chart

Fujiya Co., Ltd. (2211) FAQ

What is the stock price today?

The current price is ¥2,447.00.

On which exchange is it traded?

Fujiya Co., Ltd. is listed on JPX.

What is its stock symbol?

The ticker symbol is 2211.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.6%.

What is its market cap?

As of today, no market cap data is available.

Has Fujiya Co., Ltd. ever had a stock split?

Fujiya Co., Ltd. had 1 splits and the recent split was on Jun 28, 2017.

Fujiya Co., Ltd. Profile

Pharmaceuticals Industry
Healthcare Sector
Mr. Chuanfu Chu CEO
JPX Exchange
JP3821200007 ISIN
China Country
1,286 Employees
- Last Dividend
14 Dec 2020 Last Split
- IPO Date

Overview

Universal Health International Group Holding Limited, originally established as Jintian Pharmaceutical Group Limited in 1998, underwent a name change in July 2015 to better reflect its broadened healthcare focus. This investment holding company, rooted in the northeastern region of the People's Republic of China, specializes in the distribution and retail of a wide array of pharmaceutical and healthcare products. It prides itself on a comprehensive portfolio that encompasses drugs, healthcare items, and other pharmaceutical essentials, catering to diverse needs within the region. The company has its headquarters situated in Shenyang, establishing a significant presence in the Chinese healthcare market.

Products and Services

The product offerings of Universal Health International Group Holding Limited are vast and varied, designed to cater to a wide range of healthcare and pharmaceutical needs. These include:

  • Chinese Patent Medicines: Traditional remedies that leverage centuries-old knowledge, catering to a variety of health conditions with natural formulations.
  • Chemical Preparations: Modern pharmaceuticals developed through chemical processes, addressing a broad spectrum of health issues.
  • Antibiotics and Biochemical Drugs: Essential treatments for bacterial infections and biochemical imbalances, crucial in both acute and chronic disease management.
  • Traditional Chinese Medicine Decoction Pieces: Customized herbal treatments, tailored to individual health concerns, embodying the holistic approach of traditional Chinese medicine.
  • Biological Products: Including vaccines and biologically-derived medications, these products are vital in prevention and treatment strategies for various diseases.
  • Protein Assimilation Preparations: Supplements and products designed to aid in the body’s processing and utilization of proteins.
  • Peptide Hormones: Synthetic or natural hormones used in treating a range of health disorders, including endocrine, metabolic, and functional conditions.
  • Blood Products: Critical components for transfusions and other medical treatments, derived from human blood.
  • Disinfection Products: A range of products aimed at ensuring cleanliness and hygiene in medical and personal environments, helping prevent the spread of infections.
  • Medical Equipment: Devices and tools essential for diagnostics, treatment, and healthcare facility operations.
  • Prepackaged Foods, Nutritional Foods, Health Care Products: Items focused on wellness and nutritional support, catering to general health maintenance and specific dietary needs.
  • Stereotyped Packaging Cosmetics and Daily Necessities: A selection of personal care items and cosmetics, alongside everyday essentials for health and hygiene.
  • Family Planning Supplies: Including contraceptives and various family planning utensils, supporting reproductive health and personal choice.
  • Dairy Products, Including Infant Formula Milk Powder: Nutrition-focused offerings, especially for infants and young children, ensuring a healthy start in life.

Additionally, Universal Health International Group Holding Limited provides specialized storage services, underlining its comprehensive approach to healthcare product distribution and retail.

Contact Information

Address: No. 14-1, Bei Yi Zhong Road
Phone: -